Marina Babic

Marina Babic

Auto-generated profile, based on publicly available information

Marina Babic

Deutsches Rheuma-Forschungszentrum Berlin – ein Leibniz Institut, Berlin, Deutschland

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 August 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
TRTihana Lenac Rovis
Tihana Lenac Rovis
Paola Kučan BrlićPaola Kučan Brlić
Paola Kučan Brlić
NKNoa Kaynan
Noa Kaynan
Vanda Juranic LisnicVanda Juranic Lisnic
Vanda Juranic Lisnic
IBIlija Brizić
Ilija Brizić
SJStipan Jonjić
Stipan Jonjić
The poliovirus receptor (PVR) is a ubiquitously expressed glycoprotein involved in cellular adhesion and immune response. It engages the activating receptor DNAX accessory molecule (DNAM)-1, the inhibitory receptor TIGIT, and the CD96 receptor with both activating and inhibitory functions. Human cytomegalovirus (HCMV) down-regulates PVR expression, but the significance of this viral function in vivo remains unknown. Here, we demonstrate that mouse CMV (MCMV) also down-regulates the surface PVR. The m20.1 protein of MCMV retains PVR in the endoplasmic reticulum and promotes its degradation. A MCMV mutant lacking the PVR inhibitor was attenuated in normal mice but not in mice lacking DNAM-1. This attenuation was partially reversed by NK cell depletion, whereas the simultaneous depletion of mononuclear phagocytes abolished the virus control. This effect was associated with the increased expression of DNAM-1, whereas TIGIT and CD96 were absent on these cells. An increased level of proinflammatory cytokines in sera of mice infected with the virus lacking the m20.1 and an increased production of iNOS by inflammatory monocytes was observed. Blocking of CCL2 or the inhibition of iNOS significantly increased titer of the virus lacking m20.1. In this study, we have demonstrated that inflammatory monocytes, together with NK cells, are essential in the early control of CMV through the DNAM-1–PVR pathway.

30 May 2018 in Frontiers in Immunology
Verified
Journal Article
Open access
MBMarina Babic
Marina Babic
CRChiara Romagnani
Chiara Romagnani
Current medicine and medical science puts great effort into elucidating the basis of chronicity and finding appropriate treatments for inflammatory diseases, however, the mechanisms driving aberrant immune responses are mostly unknown and deserve further study. Of particular interest is the identification of checkpoints which regulate the function and differentiation of pro-inflammatory cells during pathogenesis, along with means of their modulation for therapeutic purposes. Natural Killer Group 2, Member D (NKG2D) is a potent activator of the immune system, known as a sensor for “induced-self” ligands, i.e. cellular danger signals that, in the context of chronic inflammation and autoimmunity, can be presented by cells being exposed to an inflammatory cytokine milieu, endoplasmic reticulum stress or cell death. Engagement by such ligands can be translated by NKG2D into activation or co-stimulation of NK cells and different subsets of T cells, respectively, thus contributing to the regulation of the inflammatory response. In this review, we discuss the current knowledge on the contribution of the NKG2D-NKG2DL signaling axis during intestinal inflammation, type 1 diabetes, multiple sclerosis and rheumatoid arthritis, where the role of NKG2D has been associated either by aberrant expression of the receptor and its ligands and/or by functional data in corresponding mouse models.

3 August 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
MBMarina Babic
Marina Babic
CDChristoforos Dimitropoulos
Christoforos Dimitropoulos
QHQuirin Hammer
Quirin Hammer
CSChristina Stehle
Christina Stehle
FHFrederik Heinrich
Frederik Heinrich
CRChiara Romagnani
Chiara Romagnani
NKG2D is a danger sensor expressed on different subsets of innate and adaptive lymphocytes. Despite its established role as a potent activator of the immune system, NKG2D-driven regulation of CD4+ T helper (Th) cell–mediated immunity remains unclear. In this study, we demonstrate that NKG2D modulates Th1 and proinflammatory T-bet+ Th17 cell effector functions in vitro and in vivo. In particular, NKG2D promotes higher production of proinflammatory cytokines by Th1 and T-bet+ Th17 cells and reinforces their transcription of type 1 signature genes, including Tbx21. Conditional deletion of NKG2D in T cells impairs the ability of antigen-specific CD4+ T cells to promote inflammation in vivo during antigen-induced arthritis and experimental autoimmune encephalomyelitis, indicating that NKG2D is an important target for the amelioration of Th1- and Th17-mediated chronic inflammatory diseases.

29 May 2019 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
JŽJelena Železnjak
Jelena Železnjak
Vanda Juranic LisnicVanda Juranic Lisnic
Vanda Juranic Lisnic
BPBranka Popović
Branka Popović
BLBerislav Lisnić
Berislav Lisnić
MBMarina Babić
Marina Babić
SJStipan Jonjić
Stipan Jonjić
CMVs efficiently target MHC I molecules to avoid recognition by cytotoxic T cells. However, the lack of MHC I on the cell surface renders the infected cell susceptible to NK cell killing upon missing self recognition. To counter this, mouse CMV (MCMV) rescues some MHC I molecules to engage inhibitory Ly49 receptors. Here we identify a new viral protein, MATp1, that is essential for MHC I surface rescue. Rescued altered-self MHC I molecules show increased affinity to inhibitory Ly49 receptors, resulting in inhibition of NK cells despite substantially reduced MHC I surface levels. This enables the virus to evade recognition by licensed NK cells. During evolution, this novel viral immune evasion mechanism could have prompted the development of activating NK cell receptors that are specific for MATp1-modified altered-self MHC I molecules. Our study solves a long-standing conundrum of how MCMV avoids recognition by NK cells, unravels a fundamental new viral immune evasion mechanism, and demonstrates how this forced the evolution of virus-specific activating MHC I–restricted Ly49 receptors.

7 April 2022 in Zeitschrift für Rheumatologie
Verified
Journal Article
Closed access
PDF file
MBMarina Babic
Marina Babic
CRChiara Romagnani
Chiara Romagnani